Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia.

Autor: Alvarez-Larrán A; Hospital Clínic Barcelona, Spain., Cuevas B; Hospital Universitario de Burgos, Spain., Velez P; Hospital de Mar, Barcelona, Spain., Noya S; Complexo Hospitalario Universitario de A Coruña, Spain., Caballero-Navarro G; Hospital Miguel Servet, Zaragoza, Spain., Ferrer-Marín F; Hospital Morales Messeguer, CIBERER, UCAM, IMIB, Murcia, Spain., Carbonell S; Hospital Clínic Barcelona, Spain., Pérez-Encinas M; Hospital Clínico Universitario de Santiago de Compostela, Spain., Gómez-Casares MT; Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain., Pérez-López R; Hospital Virgen de la Arrixaca, Murcia, Spain., Magro E; Hospital Príncipe de Asturias, Alcalá de Henares, Spain., Moretó A; Hospital de Cruces, Barakaldo, Spain., Pastor-Galán I; Hospital Clínico Universitario, Valencia, Spain., Angona A; Hospital Doctor Josep Trueta, Girona, Spain., Mata-Vázquez MI; Hospital Costa del Sol, Marbella, Spain., Guerrero-Fernández L; Complejo Asistencial de Palencia, Spain., Guerra JM; Hospital Son Llatzer, Palma de Mallorca, Spain., Carreño-Tarragona G; Hospital Universitario 12 de octubre, Madrid, Spain., Fox L; Hospital Universitario Vall d'Hebron, Barcelona, Spain., Murillo I; Hospital General San Jorge, Huesca, Spain., García-Gutiérrez V; Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain., Mora E; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Stuckey R; Hospital Virgen de la Arrixaca, Murcia, Spain., Arellano-Rodrigo E; Hospital Clínic Barcelona, Spain., Hernández-Boluda JC; Hospital Clínico Universitario, Valencia, Spain., Pereira A; Hospital Clínic Barcelona, Spain.

Publikováno v: HemaSphere [Hemasphere] 2023 Jul 18; Vol. 7 (8), pp. e936. Date of Electronic Publication: 2023 Jul 18 (Print Publication: 2023).

Utilization of sago grub (Rhynchophorus ferrugineus Olivier) (Coleoptera: Curculionidae) as an alternative source of protein.

Autor: Leatemia, J A, Patty, J A, Masauna, E D, Noya, S H, Hasinu, J V

Publikováno v: IOP Conference Series: Earth & Environmental Science; 2021, Vol. 800, p1-7, 7p

Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes

Autor: Alvarez-Larran, A, Martinez, D, Arenillas, L, Rubio, A, Arellano-Rodrigo, E, Boluda, JCH, Papaleo, N, Caballero, G, Martinez, C, Ferrer-Marin, F, Mata, MI, Perez-Encinas, M, Duran, MA, Alonso, JM, Carreno-Tarragona, G, Noya, S, Magro, E, Perez, R, Lopez-Guerra, M, Pastor-Galan, I, Cervantes, F, Besses, C, Colomo, L, Rozman, M

Publikováno v: JOURNAL OF CLINICAL PATHOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Aim To characterise the clinical and histological features of MPL-mutated essential thrombocythaemia (ET). Patients and methods Bone marrow biopsies of 175 patients with ET were centrally reviewed according to the 2016 WHO classification, including 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::325354b93671c65520a389714eb6f329
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14009

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Modulation of sleep/wake patterns by gephyrin phosphorylation status.

Autor: Tsai YC; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland., ElGrawani W; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland., Muheim C; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland., Spinnler A; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland., Campbell BFN; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland., Lasic D; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland., Hleihil M; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Brown SA; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland., Tyagarajan SK; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.

Publikováno v: The European journal of neuroscience [Eur J Neurosci] 2024 Oct; Vol. 60 (7), pp. 5431-5449. Date of Electronic Publication: 2024 Jul 19.